TELA Bio, Inc.
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355
June 23, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
100 F Street NE
Washington, D.C. 20549
Attn: Jason L. Drory
|Re:||TELA Bio, Inc.|
|Registration Statement on Form S-1|
|SEC File No. 333-239386|
|Filed June 23, 2020|
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-239386) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 PM, eastern time, on June 25, 2020, or as soon thereafter as is practicable.
Please feel free to direct any questions or comments concerning this request to Rachael Bushey, Esq. of Pepper Hamilton LLP at (215) 981-4331.
The Company understands that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
|TELA BIO, Inc.|
|By:||/s/ Antony Koblish|
|Name: Antony Koblish|
|Title: President and Chief Executive Officer|
Cc: Rachael Bushey, Pepper Hamilton LLP